FindTrial
Sign In

Efficacy of Auriculotherapy in treatment of chronic pain caused by Chikungunya

Efficacy of Auriculotherapy in Analgesia of chronic pain caused by Chikungunya: randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4hb9qs
Enrollment
Unknown
Registered
2020-04-22
Start date
2018-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chikungunya

Interventions

Experimental group: auriculotherapy, once a week, with mustard seeds and adhesive tape in points with analgesic effect in 55 patients with Chikungunya for six weeks Control group: placing adhesive tap
Procedure/surgery
Dietary supplement
E02.190.204

Sponsors

Fundação Oswaldo Cruz
Lead Sponsor
Fundação Oswaldo Cruz
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: have a clinical and / or laboratory diagnosis of chikungunya; having been in pain for at least three months; be aged between 18 and 80 years; having preserved cognitive functions

Exclusion criteria

Exclusion criteria: having a previous cancer diagnosis; being on immunosuppressive drugs; have been hospitalized up to 30 days before the start of auriculotherapy sessions

Design outcomes

Primary

MeasureTime frame
It is expected to find analgesia, using the Visual Analog Scale for Pain, from the finding of a score below 5 in the pre and post-intervention measurements—

Secondary

MeasureTime frame
It is expected to find analgesia, using the Visual Analog Scale for Pain, based on the verification of a score below 7 after 50% of the intervention was performed—

Countries

Brazil

Contacts

Public ContactMárcio Flávio Moura de Araújo

Fundação Oswaldo Cruz

oicam29@gmail.com+55-085-32156450

Outcome results

None listed

Source: REBEC (via WHO ICTRP)